3164 — GenMont Biotech Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD1.98bn
- TWD1.84bn
- TWD318.02m
- 36
- 23
- 31
- 15
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 75.5 | 76.8 | 139 | 66.3 | 28.2 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 4.71 | 1.64 | -14.7 | 4.66 | -17.8 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -27 | 18.9 | -34.2 | 16.6 | -40.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 74.5 | 118 | 112 | 138 | 34.6 |
Capital Expenditures | -394 | -139 | -117 | -71.2 | -35.5 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 398 | 146 | -36 | -12.5 | -39.8 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 4.42 | 6.78 | -153 | -83.7 | -75.4 |
Financing Cash Flow Items | 33.8 | 86.2 | 0 | 5.35 | 0 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -101 | -49.3 | -61.4 | -91.1 | -36.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -33.6 | 83.2 | -105 | -36.3 | -78.1 |